Fatal breakthrough infection with Fusarium andiyazi: new multi-resistant aetiological agent cross-reacting with Aspergillus galactomannan enzyme immunoassay

scientific article published on 6 October 2013

Fatal breakthrough infection with Fusarium andiyazi: new multi-resistant aetiological agent cross-reacting with Aspergillus galactomannan enzyme immunoassay is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/MYC.12142
P698PubMed publication ID24612042
P5875ResearchGate publication ID260681209

P2093author name stringAhmet Ursavaş
Beyza Ener
Anne D van Diepeningen
Abdullah M S Al-Hatmi
Vildan Ozkocaman
Halis Akalın
Martin Meijer
Ezgi D Cetinoğlu
Nesrin Kebabcı
Tuba Ersal
P2860cites workBreakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxisQ46405007
Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay.Q51185280
Galactomannan testing might be useful for early diagnosis of fusariosisQ59294662
GenBankQ21056874
MrBayes 3.2: Efficient Bayesian Phylogenetic Inference and Model Choice Across a Large Model SpaceQ27860804
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropeniaQ28284944
Aspergillosis case-fatality rate: systematic review of the literatureQ31918085
Internet-Accessible DNA Sequence Database for Identifying Fusaria from Human and Animal InfectionsQ33649483
Human fusariosisQ33975373
Epidemiology and outcome of zygomycosis: a review of 929 reported casesQ34440240
Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysisQ34514484
Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assayQ35806844
Multiple evolutionary origins of the fungus causing Panama disease of banana: concordant evidence from nuclear and mitochondrial gene genealogiesQ35900575
Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experienceQ35944724
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/Q37164067
Therapeutic drug monitoring of posaconazole: a monocentric study with 54 adultsQ37450660
Molecular identification of Fusarium species in Gibberella fujikuroi species complex from rice, sugarcane and maize from Peninsular MalaysiaQ38987796
Alternaria alternata invasive fungal infection in a patient with Fanconi's anemia after an unrelated bone marrow transplantQ40257946
Posaconazole prophylaxis in patients with acute myelogenous leukaemia--results from an observational studyQ40340742
Posaconazole therapeutic drug monitoring: a reference laboratory experienceQ43128336
Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009.Q43170662
P433issue4
P921main subjectFusarium andiyaziQ10500282
P304page(s)249-255
P577publication date2013-10-06
P1433published inMycosesQ1956531
P1476titleFatal breakthrough infection with Fusarium andiyazi: new multi-resistant aetiological agent cross-reacting with Aspergillus galactomannan enzyme immunoassay
P478volume57